Antifibrinolytic agents in traumatic haemorrhage.
journal contribution
posted on 2012-10-24, 09:02 authored by Timothy J. Coats, Beverly Hunt, Ian Roberts, Haleema ShakurThis article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage), a large, multi-centre, randomised controlled trial of a simple and widely practicable treatment for traumatic hemorrhage. The rationale for the trial and contact details for those who would like to take part are given below. [Introduction]
History
Citation
PLOS Medicine, 2005, 2 (3), e64Version
- VoR (Version of Record)
Published in
PLOS MedicinePublisher
Public Library of Scienceeissn
1549-1676Copyright date
2005Available date
2012-10-24Publisher DOI
Publisher version
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020064Language
engAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC